David Venables has a wide range of work experience in the life sciences industry. David is currently the CEO of Laverock Therapeutics and a Non-Executive Director at Axol Bioscience Ltd. In 2021, they also became an Honorary Professor at the University of Edinburgh's College of Medicine & Veterinary Medicine. Prior to this, they were the President of AskBio Europe from 2020-2021, CEO of Synpromics Ltd from 2014-2020, VP-CMC of NightstaRx from 2013-2014, CEO of Anatara Lifesciences Ltd from 2013-2014, Non-Executive Director and CEO of Ark Therapeutics Plc from 2012-2013, and Chief Operating Officer of Intercell USA Inc from 2010-2012.
David Venables received their Honours degree in Microbiology from the University of Surrey in 1990. David then went on to pursue a PhD in Mammalian cell fermentation at the same university, which they completed in 1993.
This person is not in the org chart
This person is not in any teams
This person is not in any offices